Introduction

　　The Nuclear Medicine Department was established in 1996 and has been a key specialty of Shenzhen Second People’s Hospital since its inception. Initially staffed by only one doctor and one nurse with a single SPECT/CT scanner and a thyroid function analyzer, the department has grown significantly over the past 28 years. Today, it employs 18 professionals and is equipped with advanced imaging and diagnostic equipment, including a PET/CT scanner, a SPECT/CT scanner, and a thyroid function analyzer. The department also operates a dedicated thyroid disease outpatient clinic and specializes in the diagnosis and treatment of thyroid-related conditions such as hyperthyroidism, thyroid cancer, and thyroid nodules, while offering a range of other nuclear medicine services.

　　Specialty Highlights

　　The department focuses on nuclear medicine diagnostics and treatments centered around thyroid diseases, serving approximately 25,000 outpatient visits annually. In addition to thyroid-related services, the department provides the following advanced diagnostic and therapeutic services:

　　•PET/CT Functional and Metabolic Imaging:

　　•Tumor screening and malignancy differentiation.

　　•Tumor staging and therapeutic response evaluation (PERCIST).

　　•Assistance in radiotherapy biological target delineation.

　　•Cardiac assessments: myocardial viability and ischemia diagnosis with treatment evaluation.

　　•Neurological and psychiatric conditions: Alzheimer’s disease, epilepsy, depression, schizophrenia, and brain function research.

　　•SPECT/CT Functional and Metabolic Imaging:

　　•Applications:

　　•Static thyroid imaging and salivary gland imaging.

　　•Whole-body bone scans.

　　•Renal dynamic imaging with split renal function analysis.

　　•Myocardial perfusion and brain perfusion imaging.

　　•Pulmonary ventilation imaging for assessing major organ functionality.

　　•Radionuclide Therapy:

　　•Techniques:

　　•131I Therapy: Treatment for hyperthyroidism and differentiated thyroid cancer.

　　•89SrCl Therapy: Palliative treatment for bone metastases.

　　•125I Radioactive Seed Implantation: Tumor-targeted therapy.

　　•90Sr Patches: Treatment for skin hemangiomas and hypertrophic scars.

　　The department’s continuous advancement in nuclear medicine diagnostics and treatments ensures comprehensive care for patients and contributes to cutting-edge research in the field. It remains a leader in thyroid disease management and other nuclear medicine applications in the region.